- Home
- AVA vs ARQT Comparison
AVA vs ARQT Comparison
Compare AVA & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AVA | ARQT |
|---|---|---|
| Founded | 1889 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Power Generation | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.3B |
| IPO Year | 1994 | 2020 |
Fundamental Metrics
Financial Performance| Metric | AVA | ARQT |
|---|---|---|
| Price | $41.52 | $20.69 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | ★ $39.00 | $34.00 |
| AVG Volume (30 Days) | 442.1K | ★ 1.9M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | ★ 4.84% | N/A |
| EPS Growth | 3.93 | ★ 88.79 |
| EPS | ★ 1.11 | N/A |
| Revenue | ★ $1,964,000,000.00 | $376,072,000.00 |
| Revenue This Year | $3.11 | $34.85 |
| Revenue Next Year | $4.44 | $29.39 |
| P/E Ratio | $36.91 | ★ N/A |
| Revenue Growth | 1.34 | ★ 91.34 |
| 52 Week Low | $35.50 | $12.72 |
| 52 Week High | $43.50 | $31.77 |
Technical Indicators
Market Signals| Indicator | AVA | ARQT |
|---|---|---|
| Relative Strength Index (RSI) | 56.49 | 41.95 |
| Support Level | $40.08 | $19.60 |
| Resistance Level | $42.02 | $24.56 |
| Average True Range (ATR) | 0.69 | 1.26 |
| MACD | 0.05 | -0.07 |
| Stochastic Oscillator | 93.24 | 28.34 |
Price Performance
Historical ComparisonAbout AVA Avista Corporation
Avista Corp is an electric and natural gas utility company. The company has two business segments including Avista Utilities, which provides electric distribution and transmission, and natural gas distribution services in parts of eastern Washington and northern Idaho, and also provides natural gas distribution service in parts of northeastern and southwestern Oregon. Avista Utilities has electric generating facilities in Washington, Idaho, Oregon, and Montana. AEL&P segment is a regulated utility providing electric services in Juneau, Alaska that is a wholly-owned subsidiary and the primary operating subsidiary of AERC.
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.